U.S. Stem Cell competitors

U.S. Stem Cell Competitors include Vital Therapies, Cannabis Sativa, CTD Holdings and Enanta Pharmaceuticals.
Add company...
U.S. Stem Cell
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Vital Therapies
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Cannabis Sativa
Cannabis Sativa
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
CTD Holdings
CTD Holdings
CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.
Enanta Pharmaceuticals
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
Founding Date
Founding Date
N/A
Founding Date
2003
Founding Date
2012
Founding Date
1990
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Sunrise, US HQ
Locations
San Diego, US HQ
Locations
Mesquite, US HQ
Locations
Alachua, US HQ
Locations
Watertown, US HQ
Employees
Employees
3
Employees
9711% increase
Employees
2
Employees
9
Employees
89
Valuation ($)
Valuation ($)
9.5 m
Valuation ($)
9.4 m
Valuation ($)
56.8 m
Valuation ($)
35.5 m
Valuation ($)
1.4 b
Twitter followers
Twitter followers
1.8 k
Twitter followers
N/A
Twitter followers
107
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$5.5m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$11.6k (FY, 2015)
Revenue (est.)
N/A
Revenue (est.)
$206.6m (FY, 2018)
Cost of goods
Cost of goods
$1.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
$5.8k (FY, 2015)
Cost of goods
$132.9k (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$3.6m (FY, 2017)
Gross profit
N/A
Gross profit
$5.8k (FY, 2015)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($3.5m) (FY, 2017)
Net income
($52.1m) (FY, 2017)
Net income
($7.4m) (FY, 2015)
Net income
($3.8m) (FY, 2017)
Net income
$72m (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 160.2m
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
$ 9.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Vital Therapies
HQ
San Diego, US
Employees
97↑ 11% increase

Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.

View company
Cannabis Sativa
HQ
Mesquite, US
Employees
2

Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.

View company
CTD Holdings
HQ
Alachua, US
Employees
9

CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.

View company
Enanta Pharmaceuticals
HQ
Watertown, US
Employees
89

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.

View company